Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 09, 2021

SELL
$56.61 - $80.46 $2.93 Million - $4.16 Million
-51,724 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$86.23 - $125.19 $1.29 Million - $1.88 Million
15,000 Added 40.85%
51,724 $4.81 Million
Q4 2020

Feb 09, 2021

SELL
$79.17 - $111.47 $1.6 Million - $2.25 Million
-20,177 Reduced 35.46%
36,724 $3.29 Million
Q3 2020

Nov 09, 2020

SELL
$81.91 - $134.94 $200,843 - $330,872
-2,452 Reduced 4.13%
56,901 $5.88 Million
Q2 2020

Aug 12, 2020

BUY
$54.33 - $89.52 $47,484 - $78,240
874 Added 1.49%
59,353 $4.69 Million
Q1 2020

May 04, 2020

BUY
$49.34 - $68.76 $1.04 Million - $1.44 Million
20,979 Added 55.94%
58,479 $3.39 Million
Q4 2019

Feb 12, 2020

SELL
$51.21 - $59.06 $1.28 Million - $1.47 Million
-24,948 Reduced 39.95%
37,500 $2.02 Million
Q3 2019

Nov 12, 2019

SELL
$40.6 - $57.2 $1.29 Million - $1.81 Million
-31,700 Reduced 33.67%
62,448 $3.27 Million
Q2 2019

Aug 16, 2019

SELL
$39.92 - $53.86 $2.86 Million - $3.86 Million
-71,600 Reduced 43.2%
94,148 $4.55 Million
Q1 2019

May 13, 2019

SELL
$48.23 - $66.16 $396,402 - $543,769
-8,219 Reduced 4.72%
165,748 $8.37 Million
Q4 2018

Feb 05, 2019

BUY
$55.63 - $73.24 $1.46 Million - $1.93 Million
26,304 Added 17.81%
173,967 $10.3 Million
Q3 2018

Nov 07, 2018

SELL
$52.05 - $66.51 $1.46 Million - $1.87 Million
-28,127 Reduced 16.0%
147,663 $9.72 Million
Q2 2018

Aug 10, 2018

BUY
$48.33 - $55.64 $2.11 Million - $2.43 Million
43,689 Added 33.07%
175,790 $8.88 Million
Q1 2018

May 08, 2018

BUY
$44.44 - $54.39 $399,471 - $488,911
8,989 Added 7.3%
132,101 $6.96 Million
Q4 2017

Feb 13, 2018

BUY
$37.77 - $47.75 $1.46 Million - $1.85 Million
38,679 Added 45.81%
123,112 $5.72 Million
Q3 2017

Nov 07, 2017

BUY
$34.14 - $40.45 $711,545 - $843,058
20,842 Added 32.78%
84,433 $3.42 Million
Q2 2017

Nov 20, 2017

BUY
N/A
63,591
63,591 $2.16 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $438M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.